Debmalya Barh

Summary

Publications

  1. ncbi Biomarkers, critical disease pathways, drug targets, and alternative medicine in male breast cancer
    Debmalya Barh
    Centre for Genomics and Applied Gene Technology, IIOAB, Nonakuri, Purba Medinipur, WB 721172, India
    Curr Drug Targets 10:1-8. 2009
  2. ncbi Molecular features, markers, drug targets, and prospective targeted therapeutics in cardiac myxoma
    Debmalya Barh
    Centre for Genomics and Applied Gene Technology, IIOAB, Nonakuri, Purba Medinipur, West Bengal, India
    Curr Cancer Drug Targets 9:705-16. 2009
  3. ncbi In silico identification of candidate drug and vaccine targets from various pathways in Neisseria gonorrhoeae
    Debmalya Barh
    Institute of Integrative Omics and Applied Biotechnology IIOAB, Nonakuri, India
    In Silico Biol 9:225-31. 2009
  4. ncbi A novel comparative genomics analysis for common drug and vaccine targets in Corynebacterium pseudotuberculosis and other CMN group of human pathogens
    Debmalya Barh
    Centre for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Biotechnology, Nonakuri, Purba Medinipur, West Bengal, India
    Chem Biol Drug Des 78:73-84. 2011

Detail Information

Publications4

  1. ncbi Biomarkers, critical disease pathways, drug targets, and alternative medicine in male breast cancer
    Debmalya Barh
    Centre for Genomics and Applied Gene Technology, IIOAB, Nonakuri, Purba Medinipur, WB 721172, India
    Curr Drug Targets 10:1-8. 2009
    ....
  2. ncbi Molecular features, markers, drug targets, and prospective targeted therapeutics in cardiac myxoma
    Debmalya Barh
    Centre for Genomics and Applied Gene Technology, IIOAB, Nonakuri, Purba Medinipur, West Bengal, India
    Curr Cancer Drug Targets 9:705-16. 2009
    ..The present review describes the current data and discusses critical issues in the field of targeted and personalized medicine of CM...
  3. ncbi In silico identification of candidate drug and vaccine targets from various pathways in Neisseria gonorrhoeae
    Debmalya Barh
    Institute of Integrative Omics and Applied Biotechnology IIOAB, Nonakuri, India
    In Silico Biol 9:225-31. 2009
    ..Screening of the functional inhibitors against these novel targets may result in discovery of novel therapeutic compounds that can be effective against antibiotic resistant strains...
  4. ncbi A novel comparative genomics analysis for common drug and vaccine targets in Corynebacterium pseudotuberculosis and other CMN group of human pathogens
    Debmalya Barh
    Centre for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Biotechnology, Nonakuri, Purba Medinipur, West Bengal, India
    Chem Biol Drug Des 78:73-84. 2011
    ..Six important targets were subjected to virtual screening, and one compound was found to be potent enough to render two targets (cdc and nrdL). We are currently validating all identified targets and lead compounds...